Reaction Details |
| Report a problem with these data |
Target | Apolipoprotein L1 |
---|
Ligand | BDBM615085 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Trypanosoma brucei Brucei Lysis Assay |
---|
IC50 | 600±n/a nM |
---|
Citation | CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F INHIBITORS OF APOL1 AND METHODS OF USING SAME US Patent US20230271945 Publication Date 8/31/2023 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Apolipoprotein L1 |
---|
Name: | Apolipoprotein L1 |
Synonyms: | APOL | APOL1 | APOL1_HUMAN | Apo-L | ApoL-I | Apolipoprotein L | Apolipoprotein L-I | Apolipoprotein L1 |
Type: | PROTEIN |
Mol. Mass.: | 43969.63 |
Organism: | Homo sapiens |
Description: | ChEMBL_120089 |
Residue: | 398 |
Sequence: | MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTM
DPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLAR
QMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSG
SLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQA
HDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHAS
ASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLH
EGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL
|
|
|
BDBM615085 |
---|
n/a |
---|
Name | BDBM615085 |
Synonyms: | 3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (2) | US20230271945, Compound 2 | US20230271945, Compound 88 | US20230271945, Compound 89 |
Type | Small organic molecule |
Emp. Form. | C21H18F3N3O3 |
Mol. Mass. | 417.3811 |
SMILES | O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| |
Structure |
|